
• Reported GAAP EPS of -$0.36 up 32.08% YoY • Reported revenue of $613.85M down -2.47% YoY • For the full year of 2026, Teladoc Health expects revenue of $2,481 - $2,576 million, Adjusted EBITDA of $267 - $306 million, and free cash flow of $130 - $170 million.
Bullish
Teladoc Health improved its net loss by 31% and grew Integrated Care segment revenue by 2%. The company continues to focus on product innovation and leveraging its platform's unique strengths for growth.
Bearish
Teladoc Health saw a 2% revenue decline, driven by a 9% decrease in BetterHelp segment revenue and paying users. The company also reported increased free cash flow outflow and faces market competition risks.